Arphra
live
S&P 5000.34+0.35%
NASDAQ0.000.00%
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1604+0.24%
GOLD4,303.8+1.45%
WTI81.11-5.50%
BTC65,514.43+3.44%
S&P 5000.34+0.35%
NASDAQ0.000.00%
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1604+0.24%
GOLD4,303.8+1.45%
WTI81.11-5.50%
BTC65,514.43+3.44%

VIJAYA.BO

Vijaya Diagnostic Centre Limited
HealthcareMedical - Diagnostics & ResearchININRPeers →Country macro →
$1,288.20
Jun 12, 2026
AI Brief
Market cap
$131.81B
52w range
P / E
EPS · FY 2026
$16.79
Volume
Revenue · FY 2026
$8.14B

Explain this page

Arphra AI
Business description
· company · SEC profile

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited offers a broad spectrum of diagnostic solutions to patients throughout India. The company's comprehensive services encompass both laboratory investigations—including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, and molecular diagnostics—and advanced imaging modalities. These imaging options feature CT scans, magnetic resonance imaging (MRI), ultrasound, digital X-rays, alongside specialized diagnostic procedures in areas like cardiology, gastroenterology, nuclear medicine, PET/CT, multidetector computed tomography, and MRI-3T. Beyond these, the company extends its care through health check-up packages and convenient home sample collection. Established in Hyderabad, India, in 1981, Vijaya Diagnostic Centre has a long-standing presence in the healthcare sector.

Founded
IPO
Sep 14, 2021
Employees
2,053
HQ
Hyderabad
CEO
Sura Suprita Reddy
CFO
Exchange
BSE
Fiscal year
Identifiers
· company_identifiers
CIK
CUSIP
ISININE043W01024
FIGIVIJAYA IB
LEI
Cross-listings
· companies · ISIN
  • VIJAYA.NSPrimaryNational Stock Exchange of IndiainINR$1.39B
  • VIJAYA.BOBombay Stock ExchangeinINR$1.39B
The global universe keeps only the primary listing; the other venues for this security are shown here.